Login

Orbis' CEO Jani Linna-Aro interviews Phil Stanway from Huber+Suhner AG about their partnership and business insights. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Archer Exploration: Advancing Nickel Sulfide Projects in Ontario and Quebec
00:10:00
Sales Strategy Discussion: Simplifying the Pitch and Winning Over Tough Customers
00:10:00
Educational Overview of Private Equity Investments | Robert L. Riedl, CEO , Endowment Wealth Management, Inc.
00:10:00
Deborah Gersh on Private Equity Investments in Value-Based Health Care | Deborah L. Gersh - PARTNER of Ropes & Gray LLP
00:10:00
Visionary Leader and CEO of Vittia Fertilizantes e Biológicos SA | Wilson Romanini, CEO, Vittia Fertilizantes e Biológicos SA.
00:10:00
Balanced Financial Planning: Key to a Purposeful Life
00:10:00
Understanding Financial Complexity: Kara Beth Vance Explains Timothy Financial Counsel’s Simple Levels Approach | Kara Beth, Principal , Timothy Financial Counsel.
00:10:00
Explore Ormat Technologies' turbine evolution and production tour video with English subtitles on YouTube Kids.
00:10:00
Florian Holzapfel on the Future of Medical Cannabis in Europe | Florian Holzapfel, CEO, Cantourage Group Se.
00:10:00
Challenges the norm in network morning news programs|David Plouffe,Former Senior Advisor, President Barack Obama
00:10:00
Pharmaceutical solutions at every stage|Paul McDonald,Chief Executive Officer,
00:00:00
Darren Stralow Managing Director and CEO, Bellevue Gold Ltd

© 2017 - Neuhu+